Rohin J Krishnan1, Muhammad Mukarram1, Bahareh Ghaedi1, Marco L A Sivilotti1, Natalie Le Sage1, Justin W Yan1, Paul Huang1, Mona Hegdekar1, Eric Mercier1, Marie-Joe Nemnom1, Lisa A Calder1, Andrew D McRae1, Brian H Rowe1, George A Wells1, Venkatesh Thiruganasambandamoorthy2. 1. John A. Burns School of Medicine (Krishnan), University of Hawai'i at Mānoa, Honolulu, Hawaii; Ottawa Hospital Research Institute (Krishnan, Mukarram, Ghaedi, Nemnom, Calder, Thiruganasambandamoorthy), The Ottawa Hospital, Ottawa, Ont.; Departments of Emergency Medicine (Sivilotti) and Biomedical and Molecular Sciences (Sivilotti), Queen's University, Kingston, Ont.; Department of Family Medicine and Emergency Medicine (Le Sage, Mercier), Laval University-Centre hospitalier universitaire de Québec - Université Laval Research Centre, Québec, Que.; Division of Emergency Medicine (Yan), Western University, London, Ont.; Department of Emergency Medicine (Huang), University of British Columbia, Vancouver, BC; Department of Emergency Medicine (Hegdekar), University of Manitoba, Winnipeg, Man.; Department of Emergency Medicine (Calder, Thiruganasambandamoorthy) and School of Epidemiology and Public Health (Wells, Thiruganasambandamoorthy), University of Ottawa, Ottawa, Ont.; Departments of Emergency Medicine (McRae) and Community Health Sciences (McRae), University of Calgary, Calgary, Alta.; Department of Emergency Medicine (Rowe) and School of Public Health (Rowe), University of Alberta, Edmonton, Alta. 2. John A. Burns School of Medicine (Krishnan), University of Hawai'i at Mānoa, Honolulu, Hawaii; Ottawa Hospital Research Institute (Krishnan, Mukarram, Ghaedi, Nemnom, Calder, Thiruganasambandamoorthy), The Ottawa Hospital, Ottawa, Ont.; Departments of Emergency Medicine (Sivilotti) and Biomedical and Molecular Sciences (Sivilotti), Queen's University, Kingston, Ont.; Department of Family Medicine and Emergency Medicine (Le Sage, Mercier), Laval University-Centre hospitalier universitaire de Québec - Université Laval Research Centre, Québec, Que.; Division of Emergency Medicine (Yan), Western University, London, Ont.; Department of Emergency Medicine (Huang), University of British Columbia, Vancouver, BC; Department of Emergency Medicine (Hegdekar), University of Manitoba, Winnipeg, Man.; Department of Emergency Medicine (Calder, Thiruganasambandamoorthy) and School of Epidemiology and Public Health (Wells, Thiruganasambandamoorthy), University of Ottawa, Ottawa, Ont.; Departments of Emergency Medicine (McRae) and Community Health Sciences (McRae), University of Calgary, Calgary, Alta.; Department of Emergency Medicine (Rowe) and School of Public Health (Rowe), University of Alberta, Edmonton, Alta. vthirug@ohri.ca.
Abstract
BACKGROUND: The benefit of hospital admission after emergency department evaluation for syncope is unclear. We sought to determine the association between hospital admission and detection of serious adverse events, and whether this varied according to the Canadian Syncope Risk Score (CSRS). METHODS: We conducted a secondary analysis of a multicentre prospective cohort of patients assessed in the emergency department for syncope. We compared patients admitted to hospital and discharged patients, using propensity scores to match 1:1 for risk of a serious adverse event. The primary outcome was detection of a serious adverse event in hospital for admitted patients or within 30 days after emergency department disposition for discharged patients. RESULTS: We included 8183 patients, of whom 743 (9.1%) were admitted; 658/743 (88.6%) were matched. Admitted patients had higher odds of detection of a serious adverse event (odds ratio [OR] 5.0, 95% confidence interval [CI] 3.3-7.4), nonfatal arrhythmia (OR 5.1, 95% CI 2.9-8.8) and nonarrhythmic serious adverse event (OR 6.3, 95% CI 2.9-13.5). There were no significant differences between the 2 groups in death (OR 1.0, 95% CI 0.4-2.7) or detection of ventricular arrhythmia (OR 2.0, 95% CI 0.7-6.0). Differences between admitted and discharged patients in detection of serious adverse events were greater for those with a CSRS indicating medium to high risk (p = 0.04). INTERPRETATION: Patients with syncope were more likely to have serious adverse events identified within 30 days if they were admitted to hospital rather than discharged from the emergency department. However, the benefit of hospital admission is low for patients at low risk of a serious adverse event.
BACKGROUND: The benefit of hospital admission after emergency department evaluation for syncope is unclear. We sought to determine the association between hospital admission and detection of serious adverse events, and whether this varied according to the Canadian Syncope Risk Score (CSRS). METHODS: We conducted a secondary analysis of a multicentre prospective cohort of patients assessed in the emergency department for syncope. We compared patients admitted to hospital and discharged patients, using propensity scores to match 1:1 for risk of a serious adverse event. The primary outcome was detection of a serious adverse event in hospital for admitted patients or within 30 days after emergency department disposition for discharged patients. RESULTS: We included 8183 patients, of whom 743 (9.1%) were admitted; 658/743 (88.6%) were matched. Admitted patients had higher odds of detection of a serious adverse event (odds ratio [OR] 5.0, 95% confidence interval [CI] 3.3-7.4), nonfatal arrhythmia (OR 5.1, 95% CI 2.9-8.8) and nonarrhythmic serious adverse event (OR 6.3, 95% CI 2.9-13.5). There were no significant differences between the 2 groups in death (OR 1.0, 95% CI 0.4-2.7) or detection of ventricular arrhythmia (OR 2.0, 95% CI 0.7-6.0). Differences between admitted and discharged patients in detection of serious adverse events were greater for those with a CSRS indicating medium to high risk (p = 0.04). INTERPRETATION:Patients with syncope were more likely to have serious adverse events identified within 30 days if they were admitted to hospital rather than discharged from the emergency department. However, the benefit of hospital admission is low for patients at low risk of a serious adverse event.
Authors: Giorgio Costantino; Benjamin C Sun; Franca Barbic; Ilaria Bossi; Giovanni Casazza; Franca Dipaola; Daniel McDermott; James Quinn; Matthew J Reed; Robert S Sheldon; Monica Solbiati; Venkatesh Thiruganasambandamoorthy; Daniel Beach; Nicolai Bodemer; Michele Brignole; Ivo Casagranda; Attilio Del Rosso; Piergiorgio Duca; Greta Falavigna; Shamai A Grossman; Roberto Ippoliti; Andrew D Krahn; Nicola Montano; Carlos A Morillo; Brian Olshansky; Satish R Raj; Martin H Ruwald; Francois P Sarasin; Win-Kuang Shen; Ian Stiell; Andrea Ungar; J Gert van Dijk; Nynke van Dijk; Wouter Wieling; Raffaello Furlan Journal: Eur Heart J Date: 2015-08-04 Impact factor: 29.983
Authors: Jenna VanLiere Canzoniero; Elham Afshar; Helene Hedian; Christina Koch; Daniel J Morgan Journal: JAMA Intern Med Date: 2015-06 Impact factor: 21.873
Authors: Win-Kuang Shen; Robert S Sheldon; David G Benditt; Mitchell I Cohen; Daniel E Forman; Zachary D Goldberger; Blair P Grubb; Mohamed H Hamdan; Andrew D Krahn; Mark S Link; Brian Olshansky; Satish R Raj; Roopinder Kaur Sandhu; Dan Sorajja; Benjamin C Sun; Clyde W Yancy Journal: J Am Coll Cardiol Date: 2017-03-09 Impact factor: 24.094
Authors: Marc A Probst; Erica Su; Robert E Weiss; Annick N Yagapen; Susan E Malveau; David H Adler; Aveh Bastani; Christopher W Baugh; Jeffrey M Caterino; Carol L Clark; Deborah B Diercks; Judd E Hollander; Bret A Nicks; Daniel K Nishijima; Manish N Shah; Kirk A Stiffler; Alan B Storrow; Scott T Wilber; Benjamin C Sun Journal: Ann Emerg Med Date: 2019-05-09 Impact factor: 5.721
Authors: Melissa M Garrido; Amy S Kelley; Julia Paris; Katherine Roza; Diane E Meier; R Sean Morrison; Melissa D Aldridge Journal: Health Serv Res Date: 2014-04-30 Impact factor: 3.402
Authors: Marc A Probst; Alexander T Janke; Adrian D Haimovich; Arjun K Venkatesh; Michelle P Lin; Keith E Kocher; Marie-Joe Nemnom; Venkatesh Thiruganasambandamoorthy Journal: Ann Emerg Med Date: 2022-04-27 Impact factor: 6.762